Patna: Buddha Cancer Centre, in association with Cancer Care & Cure Public Charitable Trust, successfully organized the Gynae Oncology Conclave 2025 in Patna. The academic conclave focused on advancing the prevention, diagnosis, and management of gynecological cancers through evidence-based discussions and multidisciplinary collaboration.
The conclave featured a comprehensive scientific program comprising expert lectures, panel discussions, and interactive sessions covering key areas such as immunotherapy in gynecologic malignancies, management of ovarian and cervical cancers, BRCA and germline testing, precision oncology, minimally invasive and robotic surgery, and evolving treatment strategies in uterine cancer. The sessions provided valuable clinical insights and practical guidance for oncology professionals.
The event was attended by several senior and highly experienced gynecologists from Patna, including Dr. Manju Gita Mishra, Dr. Shanti Roy, and Dr. Anita Singh. Their esteemed presence, extensive clinical experience, and valuable insights significantly enriched the academic discussions and enhanced the overall quality of the scientific proceedings.
The conclave was graced by Shri Shashank Shekhar Sinha (IAS), CEO, Swasthya Suraksha Samiti (Ayushman Bharat), Government of Bihar. Addressing the gathering, he appreciated the initiative taken by the organizers and emphasized the importance of strengthening cancer care services through academic collaboration and knowledge-sharing. He also extended his heartfelt thanks to all faculty members and delegates for their active participation and commitment toward improving women's cancer care.
The organizers expressed their sincere gratitude to all distinguished faculty members, speakers, panelists, moderators, and delegates for their valuable contributions, which played a crucial role in making the Gynae Oncology Conclave 2025 a meaningful and successful academic event. The conclave concluded with a shared commitment to advancing patient-centric, ethical, and accessible gynecological cancer care in the region.
